Chief Medical Officer of Homology Medicines, Inc. (U.S.: Nasdaq:FIXX), Cohn Gabriel, sells 1,661 shares worth $6,279

According to Homology Medicines, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Medical Officer, Cohn Gabriel disclosed selling 1,661 shares at a cost of $3.78. At the time of this transaction (Jan 05), this trade was worth $6,279 in total. As of Jan 05, Cohn Gabriel now owns 2,629 shares in total worth about $9,661.574999999999.

For the last few recent trades made by Homology Medicines, Inc. (U.S.: Nasdaq:FIXX) Chief Medical Officer, Cohn Gabriel, we have the following information:

Posted by George Daniels on Thursday January 13 2022, 1:26 PM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0